ロード中...
HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat
Histone deacetylase inhibitors (HDACi) and panobinostat in particular are currently in the focus of intensive investigation as latency reversing agents against the human immunodeficiency virus (HIV). Regretfully, HDACi have dose limiting side-effects making controlled, optimized methods for delivery...
保存先:
| 出版年: | Chem Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Royal Society of Chemistry
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003675/ https://ncbi.nlm.nih.gov/pubmed/29997778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c5sc03257a |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|